We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

220 hedge funds and large institutions have $4.52B invested in Medicines Co in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 87 increasing their positions, 62 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 22

75% more funds holding in top 10

Funds holding in top 10: 8 → 14 (+6)

62% more capital invested

Capital invested by funds: $2.79B → $4.52B (+$1.73B)

40% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 62

31% more call options, than puts

Call options by funds: $101M | Put options by funds: $77.5M

13% more funds holding

Funds holding: 195 → 220 (+25)

Holders
220
Holders Change
+25
Holders Change %
+12.82%
% of All Funds
5.48%
Holding in Top 10
14
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+75%
% of All Funds
0.35%
New
52
Increased
87
Reduced
62
Closed
22
Calls
$101M
Puts
$77.5M
Net Calls
+$23.7M
Net Calls Change
+$23.8M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$442M
2
AH
Aviva Holdings
Bahamas
+$175M
3
IAM
Iridian Asset Management
Connecticut
+$94.6M
4
Goldman Sachs
Goldman Sachs
New York
+$62.2M
5
TBC
Three Bays Capital
Massachusetts
+$62.2M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$39.5M
2
Wells Fargo
Wells Fargo
California
-$36.3M
3
TCM
Tekla Capital Management
Massachusetts
-$26.2M
4
UBS AM
UBS AM
Illinois
-$21.4M
5
Invesco
Invesco
Georgia
-$20.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$4.05M -$36.3M -796,916 -91%
NFA
77
Nationwide Fund Advisors
Ohio
$3.94M -$3.59M -78,785 -49%
Point72 Asset Management
78
Point72 Asset Management
Connecticut
$3.94M +$3.67M +80,496 New
RCM
79
RA Capital Management
Massachusetts
$3.91M – – –
Comerica Bank
80
Comerica Bank
Texas
$3.87M +$216K +4,738 +6%
GC
81
Guggenheim Capital
Illinois
$3.78M -$225K -4,942 -6%
CS
82
Candriam SCA
Luxembourg
$3.77M -$1.19M -26,000 -25%
ACM
83
Atika Capital Management
New York
$3.72M +$1.46M +32,000 +73%
YCMGA
84
York Capital Management Global Advisors
New York
$3.67M +$3.42M +75,000 New
Group One Trading
85
Group One Trading
Illinois
$3.64M +$3.4M +74,523 New
ACP
86
Acuta Capital Partners
California
$3.42M +$3.19M +70,000 New
American Century Companies
87
American Century Companies
Missouri
$3.35M +$140K +3,063 +5%
USAA
88
United Services Automobile Association
Texas
$3.24M – – –
State of Tennessee, Department of Treasury
89
State of Tennessee, Department of Treasury
Tennessee
$3.19M +$449K +9,841 +18%
EI
90
EAM Investors
California
$3.12M +$2.91M +63,753 New
CG
91
Cutler Group
California
$3.02M +$1.11M +24,284 +65%
MOACM
92
Mutual of America Capital Management
New York
$2.97M +$723K +15,858 +35%
GAMA
93
Graticule Asia Macro Advisors
New York
$2.57M +$1.21M +26,518 +102%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.55M +$270K +5,925 +13%
TPSF
95
Texas Permanent School Fund
Texas
$2.53M +$42.8K +939 +2%
IAS
96
IMA Advisory Services
Colorado
$2.48M -$1.95M -42,738 -46%
Public Sector Pension Investment Board (PSP Investments)
97
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.46M +$63.9K +1,400 +3%
UONDDL
98
University of Notre Dame du Lac
Indiana
$2.45M -$3.64M -79,878 -61%
ProShare Advisors
99
ProShare Advisors
Maryland
$2.38M -$521K -11,414 -19%
UBS Group
100
UBS Group
Switzerland
$2.38M +$1.6M +35,012 +258%
2 3
4
5 6

MDCO Hedge Fund Activity: Q1 2017 in Review

220 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2017, worth a combined $4.52B — up 62% from $2.79B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new MDCO positions and 22 closed out — a net gain of 30 holders — while 87 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $442M. The largest seller was PFM Health Sciences, cutting an estimated $39.5M.

  • 220 institutional investors held Medicines Co (MDCO) as of Q1 2017, up from 195 in Q4 2016.
  • Funds reported $4.52B of Medicines Co stock for Q1 2017, up 62% quarter-over-quarter.
  • 52 funds opened new Medicines Co positions in Q1 2017 and 22 closed out, a net change of +30 holders.
  • The largest Medicines Co buyer in Q1 2017 was BlackRock, an estimated $442M added.
  • The largest Medicines Co seller in Q1 2017 was PFM Health Sciences, an estimated $39.5M sold.

Based on aggregated 13F filings for Q1 2017.